Molecular Partners AG today reiterated its commitment to its un-partnered pipeline. This includes advancing the clinical and preclinical development pipeline and ramping up the activities in immuno-oncology.
Monthly Archives: July 2015
Molecular Partners AG today announced that Allergan, Inc. has reinforced its broad commitment to the discovery, research and development of multiple DARPin-based products in ophthalmology in collaboration with Molecular Partners.
Molecular Partners AG today announced that its partner Allergan has initiated phase III clinical trials with abicipar pegol (abicipar) for the treatment of wet age-related macular degeneration (wet AMD).